BR9608730A - Uso de benzimidazóis para a produção de um medicamento para o tratamento de leucemia - Google Patents

Uso de benzimidazóis para a produção de um medicamento para o tratamento de leucemia

Info

Publication number
BR9608730A
BR9608730A BR9608730A BR9608730A BR9608730A BR 9608730 A BR9608730 A BR 9608730A BR 9608730 A BR9608730 A BR 9608730A BR 9608730 A BR9608730 A BR 9608730A BR 9608730 A BR9608730 A BR 9608730A
Authority
BR
Brazil
Prior art keywords
benzimidazoles
leukemia
medicine
treatment
production
Prior art date
Application number
BR9608730A
Other languages
English (en)
Portuguese (pt)
Inventor
James Berger Camden
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of BR9608730A publication Critical patent/BR9608730A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
BR9608730A 1995-06-07 1996-05-22 Uso de benzimidazóis para a produção de um medicamento para o tratamento de leucemia BR9608730A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47381795A 1995-06-07 1995-06-07
PCT/US1996/007445 WO1996040122A1 (en) 1995-06-07 1996-05-22 Use of benzimidazoles for the manufacture of a medicament for the treatment of leukemia

Publications (1)

Publication Number Publication Date
BR9608730A true BR9608730A (pt) 1999-06-29

Family

ID=23881113

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9608730A BR9608730A (pt) 1995-06-07 1996-05-22 Uso de benzimidazóis para a produção de um medicamento para o tratamento de leucemia

Country Status (17)

Country Link
EP (1) EP0831816A1 (es)
JP (1) JPH11506732A (es)
KR (1) KR19990022617A (es)
CN (1) CN1186433A (es)
AR (1) AR003137A1 (es)
AU (1) AU717382B2 (es)
BR (1) BR9608730A (es)
CA (1) CA2223435A1 (es)
CZ (1) CZ391197A3 (es)
HU (1) HUP9802634A3 (es)
IL (1) IL118424A0 (es)
NO (1) NO975660L (es)
PL (1) PL324026A1 (es)
SK (1) SK168697A3 (es)
TR (1) TR199701536T1 (es)
WO (1) WO1996040122A1 (es)
ZA (1) ZA964373B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262093B1 (en) 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6177460B1 (en) 1995-04-12 2001-01-23 The Procter & Gamble Company Method of treatment for cancer or viral infections
US5770616A (en) 1995-06-07 1998-06-23 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
US6265427B1 (en) 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
US6686391B2 (en) 1995-08-04 2004-02-03 University Of Arizona Foundation N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions
US5900429A (en) 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
US6245789B1 (en) 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US6462062B1 (en) 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6608096B1 (en) 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
US6407105B1 (en) 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
EP2251010A1 (en) 2009-05-08 2010-11-17 Sygnis Bioscience GmbH & Co. KG Use of thiabendazole and derivatives thereof for the therapy of neurological conditions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL134354C (es) * 1963-05-23
FR2155888A1 (en) * 1971-10-13 1973-05-25 Agot Aime Solid anthelmintic composn - for more economical treatment of ruminants

Also Published As

Publication number Publication date
NO975660D0 (no) 1997-12-05
JPH11506732A (ja) 1999-06-15
AR003137A1 (es) 1998-07-08
AU5802096A (en) 1996-12-30
PL324026A1 (en) 1998-05-11
IL118424A0 (en) 1996-09-12
EP0831816A1 (en) 1998-04-01
WO1996040122A1 (en) 1996-12-19
TR199701536T1 (xx) 1998-02-21
NO975660L (no) 1998-02-09
AU717382B2 (en) 2000-03-23
KR19990022617A (ko) 1999-03-25
SK168697A3 (en) 1998-12-02
CA2223435A1 (en) 1996-12-19
CZ391197A3 (cs) 1998-05-13
HUP9802634A2 (hu) 1999-03-29
ZA964373B (en) 1996-09-02
HUP9802634A3 (en) 1999-05-28
CN1186433A (zh) 1998-07-01

Similar Documents

Publication Publication Date Title
BR9609093A (pt) Uso de bis-1,2,4-triazóis para produção de um medicamento para tratamento de cãncer
CY2013020I1 (el) Η χρηση μιας ενωσης ινγκενανης για την κατασκευη ενος φαρμακου για την θεραπεια του καρκινου
DE69839241D1 (de) Haltevorrichtung zur Herstellung von Präzisionsteilen
NO905431L (no) Trykkapplikator for medikament.
AR002651A1 (es) Procedimiento integrado para la producción de 1-buteno
BR9608730A (pt) Uso de benzimidazóis para a produção de um medicamento para o tratamento de leucemia
KR900011474A (ko) 혈소판감소증 치료제
FI962370A0 (fi) Laite tissuen valmistamiseksi
NO901486D0 (no) Fotopolymeriserbart belegningsmateriale.
ITGE930053A1 (it) Dispositivo per la fabbricazione di ovatte.
NO921040L (no) Stimulerende faktor for neu-reseptoren
KR920700625A (ko) 고혈압 치료를 위한 신장에 선택적인 프로드러그(Prodrug)
DE69207696D1 (de) Einschritt-Verfahren zur Herstellung von Dirithromycin
PT1083934E (pt) Egr-1 para a producao de um medicamento para o tratamento de feridas
BR9510352A (pt) Furadeira de precisão para a produção de furos desarredondados
FI935065A (fi) Farmaceutiska foereningar
MX9202890A (es) Procedimiento para la produccion de un lapiz.
EE03384B1 (et) Melatoniini kasutamine ravimi tootmiseks
FI973644A0 (fi) Uusi menetelmä 2,3-dihydrobentsofuranolijohdannaisten valmistamiseksi
DK101197A (da) Medikament til behandling af thrombocytopenia
NO982036D0 (no) Forbindelse egnet for behandling av traumatisk hjerneskade
PT866699E (pt) Utilizacao de inibidores de colinesterase para o fabrico de um medicamento para o tratamento de xerostomia
FI943759A0 (fi) Foerfarande foer att behandla organogeniska avfall och en i foerfarandet anvaendbar anordning
ITRM930141A0 (it) Procedimento per la produzione di perfluoroalchilsolfonilfloruri.
LV11966A (lv) Pretiekaisumu lidzeklis arigai lietosanai

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal